Menstrual Syndrome Drug Pristiq Ready

Menstrual Syndrome Drug Pristiq Ready

Experienced over half a century of market history, now Wyeth’s menstrual syndrome usher in a new product family members. As the new generation of drug Pristiq is expected to receive marketing authorization in the United States recently, the United States Wyeth finally have the opportunity to regroup the field of menstrual syndrome.

Wyeth’s menstrual syndrome therapy products has been good response, its flagship product, Premarin series has sold over half a century the world as long as their treatment of American women receiving nearly 4,000 people. However, as a study in 2002 found that hormone replacement therapy cause breast cancer and heart disease there is security risk, from the sale of this product line plummeted?? A large number of patients to give up this series of products, its sales from the peak of 2 billion U.S. dollars fell to 1.1 billion. At the same time, there across the United States for more than 5,000 adverse reactions Premarin lawsuits.

Fortunately, Pristiq is expected to change all that. Pristiq is currently the world’s best-selling products Wyeth antidepressant drugs Yinuo Si’s successor, but it can affect the secretion of brain chemicals to improve the flushing menstrual syndrome symptoms. At this point, Pristiq and Premarin hormone products like the traditional that there are fundamental differences, thus it is expected to become the first non-hormonal drug treatment of menstrual syndrome.

Pristiq mechanism of action and follow-up products Yinuo Si no great difference. As a dual-channel inhibitor, Pristiq and Yi Nuosi the same can also inhibit the 5 – HT and norepinephrine reuptake. Found, such as flushing, including many of menstrual syndrome and 5 – the lack of serotonin, and flushing may be triggering a rapid heart beat, dizziness, muscle weakness and fatigue issue, so, Pristiq by inhibiting the reuptake mechanism to increase 5 – serotonin and norepinephrine levels on the final treatment is a great advantage. More importantly, since Pristiq is not a hormone drugs, therefore, it can even be used for breast cancer patients with menstrual disease. In fact, Pristiq some similar products, such as Eli Lilly and Company products Yan Baida some clinical experts have been authorized for such purposes, even if it is not yet FDA approval.

However, in view of Pristiq is not a hormone drugs, according to the clinical experts to reflect its effect than its traditional products, Wyeth Premarin slightly lost the edge. Although Wyeth has not been Pristiq with Premarin to control the future research studies, but the positive is, Pristiq will be the Premarin that fear of adverse reactions drug of choice for patients with premenstrual syndrome. In addition, Pristiq daily drug costs reached four U.S. dollars, the price is the cost of Premarin daily average of 4 times.

There is no doubt speaking for Wyeth, Pristiq is not only a follow-up of its top products Yinuo Si products, it is an important guarantee of future performance. Currently, Yinuo Si’s sales reached nearly 40 million, but its patent will expire in 2010. In this sense, Pristiq will be the successful listing of significant test results Wyeth.

Now , Easy online business! Show more good products

Landed